Vaccine Hesitancy: When Political Miscommunication Replaces Scientific Benefit/Risk Assessment

Authors

  • Christian Rausch Special Advisor to the CEO, Uppsala Monitoring Centre
  • Peter J Pitts President, Center for Medicine in the Public Interest, Visiting Professor, University of Paris Medical School
  • Hervé le Louët CEO Uppsala Monitoring Centre, Professor, Université Paris-Est Créteil

DOI:

https://doi.org/10.5912/jcb1012

Abstract

Around the world, scientists, manufacturers and governments jumped into the race to develop a vaccine to combat COVID-19 and its associated lockdowns. A global response was required since defeating the pandemic requires global alignment. The availability of COVID-19 vaccines has always been a major concern for the WHO particularly in low and middle-income countries. While the vaccine development programs moved successfully forward, another problem, vaccine hesitancy, became a worrying factor in the movement towards herd immunity in many countries. Several factors contribute to this predicament. 

Published

2021-10-21